Literature DB >> 22647204

Small interfering ribonucleic acid design strategies for effective targeting and gene silencing.

Meenakshi Malhotra1, Shruti Nambiar, Venkatesh Rengaswamy, Satya Prakash.   

Abstract

INTRODUCTION: Gene silencing mediated by siRNAs is becoming a promising therapeutic approach. Although many strategies and technologies have been applied to siRNA design, a key issue lies in the selection of efficient design predictors. Furthermore, the development of systemic siRNA delivery strategies, which would enhance the therapeutic effect, remains a central issue. AREAS COVERED: The review discusses the basic principles of the sequence-specific design criteria of functional siRNAs and possible chemical modifications. Some of the most recent advances in the development of siRNA design algorithms and delivery strategies are also presented. Emphasis is given to the important design rule sets and predictors which determine the functionality of an efficient siRNA. EXPERT OPINION: The potential and limitations of efficient design predictors obtained from computational algorithms play a crucial role in the development of target-specific siRNAs. Furthermore, the future success of RNA interference therapeutics will depend on their ability to efficiently cross the physiological barriers, selectively target cells-of-interest and finally silence the gene-of-interest without any side effects.

Year:  2011        PMID: 22647204     DOI: 10.1517/17460441.2011.555394

Source DB:  PubMed          Journal:  Expert Opin Drug Discov        ISSN: 1746-0441            Impact factor:   6.098


  4 in total

1.  Systemic siRNA Delivery via Peptide-Tagged Polymeric Nanoparticles, Targeting PLK1 Gene in a Mouse Xenograft Model of Colorectal Cancer.

Authors:  Meenakshi Malhotra; Catherine Tomaro-Duchesneau; Shyamali Saha; Satya Prakash
Journal:  Int J Biomater       Date:  2013-09-15

2.  Small Interfering RNAs Are Highly Effective Inhibitors of Crimean-Congo Hemorrhagic Fever Virus Replication In Vitro.

Authors:  Fanni Földes; Mónika Madai; Henrietta Papp; Gábor Kemenesi; Brigitta Zana; Lili Geiger; Katalin Gombos; Balázs Somogyi; Ildikó Bock-Marquette; Ferenc Jakab
Journal:  Molecules       Date:  2020-12-07       Impact factor: 4.411

3.  Intranasal, siRNA Delivery to the Brain by TAT/MGF Tagged PEGylated Chitosan Nanoparticles.

Authors:  Meenakshi Malhotra; Catherine Tomaro-Duchesneau; Shyamali Saha; Satya Prakash
Journal:  J Pharm (Cairo)       Date:  2013-09-12

4.  Introducing an In Vitro Liver Stability Assay Capable of Predicting the In Vivo Pharmacodynamic Efficacy of siRNAs for IVIVC.

Authors:  Babak Basiri; Fang Xie; Bin Wu; Sara C Humphreys; Julie M Lade; Mai B Thayer; Pam Yamaguchi; Monica Florio; Brooke M Rock
Journal:  Mol Ther Nucleic Acids       Date:  2020-07-10       Impact factor: 8.886

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.